PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8

被引：41

作者：

Aquilante, Christina L. ^{[1
]}

Niemi, Mikko ^{[4
]}

Gong, Li ^{[2
]}

Altman, Russ B. ^{[2
,3
]}

Klein, Teri E. ^{[2
]}

机构：

[1] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA

[2] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA

[3] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA

[4] Univ Helsinki, Dept Clin Pharmacol, HUSLAB, Helsinki Univ Cent Hosp, SF-00250 Helsinki, Finland

来源：

PHARMACOGENETICS AND GENOMICS | 2013年 / 23卷 / 12期

关键词：

CYP2C8; CYP2C8*3; metabolism; pharmacogenetics; pharmacogenomics; pharmGKB;

D O I：

10.1097/FPC.0b013e3283653b27

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：721 / 728

页数：8

共 151 条

[81] The effect of the cytochrome P450CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects [J].

Martínez, C ;

García-Martín, E ;

Blanco, G ;

Gamito, FJG ;

Ladero, JM ;

Agúndez, JAG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) :62-69

[82] Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes [J].

Martis, S. ;

Peter, I. ;

Hulot, J-S ;

Kornreich, R. ;

Desnick, R. J. ;

Scott, S. A. .

PHARMACOGENOMICS JOURNAL, 2013, 13 (04) :369-377

[83] Identification of human cytochrome P450 isoforms that contribute to all-trans-Retinoic Acid 4-hydroxylation [J].

McSorley, LC ;

Daly, AK .

BIOCHEMICAL PHARMACOLOGY, 2000, 60 (04) :517-526

[84] Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer [J].

Mielke, S ;

Sparreboom, A ;

Steinberg, SM ;

Gelderblom, H ;

Unger, C ;

Behringer, D ;

Mross, K .

CLINICAL CANCER RESEARCH, 2005, 11 (13) :4843-4850

[85] The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone Metabolism In Vitro [J].

Muschler, Eugen ;

Lal, Jawahar ;

Jetter, Alexander ;

Rattay, Anke ;

Zanger, Ulrich ;

Zadoyan, Gregor ;

Fuhr, Uwe ;

Kirchheiner, Julia .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 (06) :374-379

[86] Genetic polymorphism of CYP2C8 in three Malaysian ethnics:: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians [J].

Muthiah, YD ;

Lee, WL ;

Teh, LK ;

Ong, CE ;

Ismail, R .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (05) :487-490

[87] Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes [J].

Nadin, L ;

Murray, M .

BIOCHEMICAL PHARMACOLOGY, 1999, 58 (07) :1201-1208

[88] Genetic polymorphisms of CYP2C8 in Japanese population [J].

Nakajima, M ;

Fujiki, Y ;

Noda, K ;

Ohtsuka, H ;

Ohkuni, H ;

Kyo, S ;

Inoue, M ;

Kuroiwa, Y ;

Yokoi, T .

DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) :687-690

[89] Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer [J].

Nakajima, Yukiko ;

Yoshitani, Takashi ;

Fukushima-Uesaka, Hiromi ;

Saito, Yoshiro ;

Kaniwa, Nahoko ;

Kurose, Kouichi ;

Ozawa, Shogo ;

Aoyagi, Nobuo ;

Kamatani, Naoyuki ;

Yamamoto, Noboru ;

Kunitoh, Hideo ;

Ohe, Yuichiro ;

Tamura, Tomohide ;

Yoshida, Teruhiko ;

Minami, Hironobu ;

Saijo, Nagahiro ;

Katori, Noriko ;

Sawada, Jun-ichi .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (02) :179-191

[90] Human Liver Expression of CYP2C8: Gender, Age, and Genotype Effects [J].

Naraharisetti, Suresh Babu ;

Lin, Yvonne S. ;

Rieder, Mark J. ;

Marciante, Kristin D. ;

Psaty, Bruce M. ;

Thummel, Kenneth E. ;

Totah, Rheem A. .

DRUG METABOLISM AND DISPOSITION, 2010, 38 (06) :889-893

← 4 5 6 7 8 9 10 11 12 13 →